Understanding genetic factors and misdiagnosis in cancer patients
Genetic predisposition and misdiagnosis of cancer in All of Us participants
This study is looking at how our genes might sometimes lead to incorrect cancer diagnoses, and it's for people in the All of Us program who want to help improve cancer care by sharing their genetic information.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham Young University NIH-funded |
| Lab location | 1 site (Provo, United States) |
| Project ID | NIH-10974720 on NIH RePORTER |
What this research studies
This research investigates how genetic predispositions can lead to misdiagnosis of cancer among participants in the All of Us program. By analyzing large datasets and utilizing advanced bioinformatics, the study aims to identify common genetic markers that may influence cancer diagnosis and treatment outcomes. The approach includes examining the unique characteristics of tumors and their genetic profiles to improve diagnostic accuracy and patient care. Participants may contribute their genetic information to help develop better predictive models for cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been diagnosed with cancer or are at high risk for developing cancer based on their genetic background.
Not a fit: Patients who do not have a genetic predisposition to cancer or those who have already received definitive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and personalized treatment plans for patients.
How similar studies have performed: Previous research utilizing large genomic datasets has shown promise in improving cancer diagnosis and treatment, indicating that this approach could yield significant advancements.
Where this research is happening
Provo, United States
- Brigham Young University — Provo, United States (Active)
Researchers
- Principal investigator: Bailey, Matthew H — Brigham Young University
- Study coordinator: Bailey, Matthew H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.